Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
Non-alcoholic fatty liver disease (NAFLD) and atherosclerosis (ATS) are worldwide known diseases with increased incidence and prevalence. These two are driven and are interconnected by multiple oxidative and metabolic functions such as lipotoxicity. A gamut of evidence suggests that sphingolipids (S...
Main Authors: | Daniela Maria Tanase, Evelina Maria Gosav, Daniela Petrov, Alina Ecaterina Jucan, Cristina Mihaela Lacatusu, Mariana Floria, Claudia Cristina Tarniceriu, Claudia Florida Costea, Manuela Ciocoiu, Ciprian Rezus |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/11/2053 |
Similar Items
-
Ceramides: focus on obesity
by: Yulia A. Dyleva, et al.
Published: (2020-12-01) -
Azido-Ceramides, a Tool to Analyse SARS-CoV-2 Replication and Inhibition—SARS-CoV-2 Is Inhibited by Ceramides
by: Daniela Brenner, et al.
Published: (2023-04-01) -
Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets
by: Antía Custodia, et al.
Published: (2021-06-01) -
The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy
by: Megan Sheridan, et al.
Published: (2021-05-01) -
Targeting Ceramides and Adiponectin Receptors in the Islet of Langerhans for Treating Diabetes
by: Wen-hong Li
Published: (2022-09-01)